A randomized controlled pilot trial of oral N-acetylcysteine in children with autism. Biological psychiatry 71, no
A Phase IIb study comparing cotadutide with the GLP-1R mono-agonist liraglutide showed that, after 54 weeks, cotadutide produced similar HbA 1c reductions (cotadutide vs liraglutide: 13.0 mmol/mol vs 12.8 mmol/mol [1.19% vs 1.17%]) but greater bodyweight reductions than liraglutide (5.02% vs 3.33%) [6]
By week 12, most people report that the early discomforts have faded significantly
Serum adipokines in inflammatory bowel disease
Electroporation drives active ingredients into the deep dermis, enhancing cell uptake for better results compared to superficial treatments
39-43 Since inflammation appears to play a role in cardiometabolic, immunologic, and neurodegenerative diseases, targeting it as a mechanism of disease could aid in managing multiple disorders with just a single drug